The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Lipid II as a target for antibiotics
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Neuhaus, F. C., & Baddiley, J. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.686-723.2003 · Cited by 1,031
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Applications of the bacteriocin, nisin
Delves-Broughton, J., Blackburn, P., Evans, R. J., & Hugenholtz, J. (1996) · Antonie van Leeuwenhoek · doi:10.1007/bf00399424 · Cited by 972
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Use of the Cell Wall Precursor Lipid II by a Pore-Forming Peptide Antibiotic
Breukink, E., Wiedemann, I., Kraaij, C. V., Kuipers, O. P., Sahl, H.-G., & de Kruijff, B. (1999) · Science · doi:10.1126/science.286.5448.2361 · Cited by 814
Self-citationWiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O. P., Bierbaum, G., de Kruijff, B., & Sahl, H.-G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006770200 · Cited by 790
Self-citationBiosynthesis and Mode of Action of Lantibiotics
Chatterjee, C., Paul, M., Xie, L., & van der Donk, W. A. (2005) · Chemical Reviews · doi:10.1021/cr030105v · Cited by 718
Genetics and mechanisms of glycopeptide resistance in enterococci
Arthur, M., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1563 · Cited by 694
Nisin treatment for inactivation of Salmonella species and other gram-negative bacteria
Stevens, K. A., Sheldon, B. W., Klapes, N. A., & Klaenhammer, T. R. (1991) · Applied and Environmental Microbiology · doi:10.1128/aem.57.12.3613-3615.1991 · Cited by 570
Cited by
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Biosynthesis and Mode of Action of Lantibiotics
Chatterjee, C., Paul, M., Xie, L., & van der Donk, W. A. (2005) · Chemical Reviews · doi:10.1021/cr030105v · Cited by 718
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
New antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Application of bacteriocins and protective cultures in dairy food preservation
Silva, C. C. G., Silva, S. P. M., & Ribeiro, S. C. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00594 · Cited by 601
Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides
Malanovic, N., & Lohner, K. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.004 · Cited by 586
Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., Nielsen, A. K., Mygind, P. H., Raventós, D. S., et al. (2010) · Science · doi:10.1126/science.1185723 · Cited by 550
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes
Repka, L. M., Chekan, J. R., Nair, S. K., & van der Donk, W. A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00591 · Cited by 547
An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II
Hasper, H. E., Kramer, N. E., Smith, J. L., Hillman, J. D., Zachariah, C., Kuipers, O. P., de Kruijff, B., & Breukink, E. (2006) · Science · doi:10.1126/science.1129818 · Cited by 501
Self-citationGharsallaoui, A., Oulahal, N., Joly, C., & Degraeve, P. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.763765 · Cited by 459
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
The biosynthesis of peptidoglycan lipid-linked intermediates
Bouhss, A., Trunkfield, A. E., Bugg, T. D. H., & Mengin-Lecreulx, D. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00089.x · Cited by 446
α‐Defensins in human innate immunity
Lehrer, R. I., & Lu, W. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01082.x · Cited by 429
Challenges for the effective molecular imprinting of proteins
Verheyen, E., Schillemans, J. P., van Wijk, M., Demeniex, M.-A., Hennink, W. E., & van Nostrum, C. F. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.007 · Cited by 424
Antimicrobial Peptides Targeting Gram-Positive Bacteria
Malanovic, N., & Lohner, K. (2016) · Pharmaceuticals · doi:10.3390/ph9030059 · Cited by 420
Hassan, M., Kjos, M., Nes, I. F., Diep, D. B., & Lotfipour, F. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05338.x · Cited by 402
Cell envelope stress response in Gram-positive bacteria
Jordan, S., Hutchings, M. I., & Mascher, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00091.x · Cited by 387
Common mechanisms of target cell recognition and immunity for class II bacteriocins
Diep, D. B., Skaugen, M., Salehian, Z., Holo, H., & Nes, I. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608775104 · Cited by 374
Prospects for new antibiotics: a molecule-centered perspective
Walsh, C. T., & Wencewicz, T. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.49 · Cited by 372
Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin
Lubelski, J., Rink, R., Khusainov, R., Moll, G. N., & Kuipers, O. P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7171-2 · Cited by 348
Mohammadi, T., van Dam, V., Sijbrandi, R., Vernet, T., Zapun, A., Bouhss, A., Diepeveen-de Bruin, M., Nguyen-Distèche, M., de Kruijff, B., & Breukink, E. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.61 · Cited by 315
Self-citationDiscovery, Biosynthesis, and Engineering of Lantipeptides
Knerr, P. J., & van der Donk, W. A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060110-113521 · Cited by 314
Parisien, A., Allain, B., Zhang, J., Mandeville, R., & Lan, C. Q. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03498.x · Cited by 300
Antibiotics in the clinical pipeline in 2011
Butler, M. S., & Cooper, M. A. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.44 · Cited by 272
Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds
McIntosh, J. A., Donia, M. S., & Schmidt, E. W. (2009) · Natural Product Reports · doi:10.1039/b714132g · Cited by 269
An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
Schneider, T., & Sahl, H.-G. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.005 · Cited by 261
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
Wagner, S., Sommer, R., Hinsberger, S., Lu, C., Hartmann, R. W., Empting, M., & Titz, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01698 · Cited by 258
Teixobactin kills bacteria by a two-pronged attack on the cell envelope
Shukla, R., Lavore, F., Maity, S., Derks, M. G. N., Jones, C. R., Vermeulen, B. J. A., Melcrová, A., Morris, M. A., Becker, L. M., Wang, X., et al. (2022) · Nature · doi:10.1038/s41586-022-05019-y · Cited by 201
Self-citationDintner, S., Staroń, A., Berchtold, E., Petri, T., Mascher, T., & Gebhard, S. (2011) · Journal of Bacteriology · doi:10.1128/jb.05175-11 · Cited by 156
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
Chauhan, J., Cardinale, S., Fang, L., Huang, J., Kwasny, S. M., Pennington, M. R., Basi, K., diTargiani, R., Capacio, B. R., MacKerell, A. D., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164515 · Cited by 24
Nie, X., Gao, F., You, W., Chen, G., Shao, Q., Wang, L.-H., Huang, W.-Q., Xia, L., Zhang, Z., Hong, C.-Y., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.138373 · Cited by 6
Metadata
- Authors
- Breukink, E., & de Kruijff, B.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-03-10
- Volume
- 5
- Issue
- 4
- Pages
- 321-323
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1980145079
- Cited by
- 701
- References
- 77
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.